Northern America: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Northern America

The North American prophylactic medicaments containing insulin market expanded notably to $X in 2022, with an increase of 5.4% against the previous year. Overall, consumption saw a remarkable increase. Over the period under review, the market hit record highs at $X in 2020; however, from 2021 to 2022, consumption remained at a lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Northern America

In value terms, prophylactic medicaments containing insulin production amounted to $X in 2022 estimated in export price. Over the period under review, production saw a prominent increase. The growth pace was the most rapid in 2017 with an increase of 33% against the previous year. Over the period under review, production attained the maximum level at $X in 2020; however, from 2021 to 2022, production stood at a somewhat lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports in Northern America

In 2022, overseas shipments of medicaments containing insulin but not antibiotics in measured doses increased by 57% to X tons for the first time since 2019, thus ending a two-year declining trend. The total export volume increased at an average annual rate of +4.3% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. As a result, the exports reached the peak and are likely to continue growth in the immediate term.

In value terms, prophylactic medicaments containing insulin exports soared to $X in 2022. Over the period under review, exports showed a buoyant expansion. As a result, the exports attained the peak and are likely to continue growth in the immediate term.

Exports by Country

In 2022, the United States (X tons) was the key exporter of medicaments containing insulin but not antibiotics in measured doses in Northern America, achieving 100% of total export.

The United States was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics in measured doses exports, with a CAGR of +4.3% from 2012 to 2022. The shares of the largest exporters remained relatively stable throughout the analyzed period.

In value terms, the United States ($X) also remains the largest prophylactic medicaments containing insulin supplier in Northern America.

From 2012 to 2022, the average annual rate of growth in terms of value in the United States totaled +6.5%.

Export Prices by Country

The export price in Northern America stood at $X per ton in 2022, with a decrease of -4.7% against the previous year. Export price indicated a pronounced increase from 2012 to 2022: its price increased at an average annual rate of +2.1% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, prophylactic medicaments containing insulin export price increased by +71.0% against 2018 indices. The pace of growth was the most pronounced in 2020 when the export price increased by 54% against the previous year. Over the period under review, the export prices hit record highs at $X per ton in 2021, and then fell slightly in the following year.

As there is only one major export destination, the average price level is determined by prices for the United States.

From 2012 to 2022, the rate of growth in terms of prices for the United States amounted to +2.1% per year.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports in Northern America

In 2022, supplies from abroad of medicaments containing insulin but not antibiotics in measured doses increased by 8.2% to X tons, rising for the fourth year in a row after two years of decline. The total import volume increased at an average annual rate of +2.2% from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. The pace of growth was the most pronounced in 2016 with an increase of 23%. As a result, imports attained the peak of X tons. From 2017 to 2022, the growth of imports remained at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin imports dropped to $X in 2022. Over the period under review, imports, however, continue to indicate a deep reduction. The most prominent rate of growth was recorded in 2014 with an increase of 35%. As a result, imports reached the peak of $X. From 2015 to 2022, the growth of imports remained at a lower figure.

Imports by Country

The United States represented the main importer of medicaments containing insulin but not antibiotics in measured doses in Northern America, with the volume of imports recording X tons, which was approx. 74% of total imports in 2022. It was distantly followed by Canada (X tons), making up a 26% share of total imports.

From 2012 to 2022, average annual rates of growth with regard to prophylactic medicaments containing insulin imports into the United States stood at +1.4%. At the same time, Canada (+4.6%) displayed positive paces of growth. Moreover, Canada emerged as the fastest-growing importer imported in Northern America, with a CAGR of +4.6% from 2012-2022. Canada (+5.4 p.p.) significantly strengthened its position in terms of the total imports, while the United States saw its share reduced by -5.4% from 2012 to 2022, respectively.

In value terms, the United States ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in measured doses in Northern America, comprising 75% of total imports. The second position in the ranking was taken by Canada ($X), with a 25% share of total imports.

From 2012 to 2022, the average annual growth rate of value in the United States totaled -8.6%.

Import Prices by Country

In 2022, the import price in Northern America amounted to $X per ton, falling by -12.6% against the previous year. Over the period under review, the import price continues to indicate a deep slump. The pace of growth was the most pronounced in 2014 an increase of 16%. As a result, import price attained the peak level of $X per ton. From 2015 to 2022, the import prices failed to regain momentum.

Average prices varied noticeably amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was the United States ($X per ton), while Canada totaled $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Canada (-1.7%).

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :